DMD and Duchenne muscular dystrophy: The fact that DMD patients can be candidates for replacement gene therapy regardless of the underlying dystrophin mutation makes this a very attractive approach to correct DMD defects (Gregorevic et al., 2004; Chamberlain and Chamberlain, 2017; Duan, 2018a; Crudele and Chamberlain, 2019).